Mark Youssef Pharm D MBA
About
Mark Youssef Pharm D MBA is from United States. Mark is currently Global Head of Business & Corporate Development at Healx, located in New York City Metropolitan Area. In Mark's previous role as a Global Head of Business Development & Licensing at Acrotech Biopharma, Mark worked in Greater New York City Area until Mar 2021. Prior to joining Acrotech Biopharma, Mark was a Business Development and Licensing at Bayer and held the position of Business Development and Licensing at Greater New York City Area. Prior to that, Mark was a Owner and Founder at M&M Local Auto Sales, based in New Jersey from Feb 2012 to May 2017. Mark started working as Pharmacy Technician at Robert Wood Johnson University Hospital in New Brunswick, NJ in May 2012. From Sep 2015 to Oct 2015, Mark was Extern at RevHealth, based in Morristown nj. Prior to that, Mark was a Model based drug development intern at Janssen, Pharmaceutical Companies of Johnson and Johnson, based in Raritan nj from May 2014 to Aug 2014.
If you’re looking for Mark Youssef Pharm D MBA's email address, you can find it on finalscout.com. Finalscout is a professional database with more than 500 million business professionals and 200 million company profiles.
Mark Youssef Pharm D MBA's current jobs
Mark Youssef Pharm D MBA's past jobs
Business Development and Licensing at Acrotech • Lead Business Development for the company reporting directly to the CEO. • Identify, evaluate, negotiate and close licensing and acquisition opportunities across therapeutic areas including oncology, dermatology, neurology, and various rare diseases. • Present business cases to the executive chairman and board. • Submit offers and negotiate terms for acquisitions, licenses and partnerships. • Conduct strategic analysis of various therapeutic areas to identify disease areas with high unmet need. • Co-ordinate meetings and discussions with potential in-licencing and acquisition target opportunities. • Build patient based and prescription based financial models based on market research, prescription data, and other supporting data. • Maintain relationships with partner companies and negotiate terms to optimize partnerships. • Participate in various cross functional activities including screening investigator initiated study opportunities, building out our company infrastructure, co-coordinating with pharmacovigilance, regulatory and compliance for various projects, supporting forecasting and budget planning. • Evaluate and support internal development projects. • Contribute to developing and executing on the company strategy. • Manage a budget for all of Business Development.
Business Development and Licensing at Bayer. • Originated multiple attractive licensing opportunities across therapeutic areas including oncology, immunology, cardiology, neurology, and various rare diseases. • Created detailed US business case models to determine the value of opportunities by conducting market research, literature reviews, market analysis, and working with experts at Bayer. • Managed the alliance between Bayer and a partner company to transition the US rights to a previously out-licensed product back to Bayer. • Attended conferences and met with CEOs and BD&L from over 50 companies to discuss opportunities to collaborate. • Optimized the value of several established products through establishing innovative distribution and marketing deals. • Conducted strategic analysis of various therapeutic areas to identify attractive white space opportunities.
• Managed and trained several employees. • Established business relationships with wholesalers, dealerships, mechanics, and investors. • Developed strategies for selling cars efficiently and managing risk.
• Collaborated closely with multidisciplinary teams to develop marketing materials and strategies for clients such as Novartis, Merck, Pacira, BMS, and Sanofi. • Conducted research for landscaping disease states to help determine how Minastrin® should be marketed and identified characteristics of this medication that became the cornerstone of the marketing strategy. • Developed a scientific platform for Zerbaxa®. • Performed competitive intelligence research and conducted a SWOT analysis of Exparel® and other medications.
• Spearheaded the evaluation and validation of Phoenix QT+® software by working cross-functionally with statisticians, clinical developers, and other professionals. • Discovered glitches and weaknesses in the software and collaborated with the software developer to improve the program. • Presented results and experiences with the program to various departments at Janssen and Certara.